Novogen Limited (ADR) (NASDAQ:NVGN)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of phenolic technology.


Player Avatar zzlangerhans (99.85) Submitted: 3/26/2013 8:30:35 AM : Underperform Start Price: $4.80 NVGN Score: +10.65

I'm still short 1000 shares of Novogen at 4.5 and looking for a gain of at least a thousand bucks before I spit this one out. I had to laugh when the stock more than doubled from where I shorted it. I can't remember the last time a spike on a PR this weak didn't die out the same day the news came out. But of course Novogen had to be the one that had legs. 4.5 might be the new floor for now, but wait until the company decides the coast is clear for a little dilution. Meanwhile, I've decided that shorting is more fun than I thought it would be. Look for a few more nailbiters from me on the short side in the near future.

Featured Broker Partners